Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update on SHR-1020 plus albumin-bound paclitaxel for second-line pancreatic cancer treatment reported efficacy and …
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating timing of systemic treatment initiation in asymptomatic metastatic pancreatic cancer; results not yet disclosed.
-
FDA approval · 2021-05-10FDA Approved: ERLOTINIB HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved the original ANDA for erlotinib hydrochloride (generic) from Novadoz Pharmaceuticals LLC, making a generic version availabl…
-
CLINICAL_TRIALS withdrawal · 2021-05-07Clinical Trial Update: An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer [Phase 3]
An extension phase 3 trial of methylnaltrexone bromide in advanced pancreatic cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-05-07Clinical Trial Update: A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer [Phase 2, Phase 3]
A study of methylnaltrexone bromide (MNTX) in advanced pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer [Phase 1]
Phase 1 dose-escalation safety study of locally-delivered gemcitabine in pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for metronomic chemotherapy with capecitabine in pancreatic cancer (Phase 2 and Phase 3).
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update on everolimus, cetuximab, and capecitabine in metastatic pancreatic cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Metformin Combined With Chemotherapy for Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update on metformin combined with chemotherapy for locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy [Phase 4]
A Phase 4 trial comparing EUS-Coeliac Plexus Block to radiofrequency ablation for pain relief in patients with pancreatic cancer/pancreatic …
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) [Phase 1]
Phase 1 trial of TAK-164 in advanced GI cancers expressing GCC was terminated; results posted in 2021.
-
CLINICAL_TRIALS withdrawal · 2021-03-19Clinical Trial Update: Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma [Phase 3]
Phase 3 trial of eus-guided cryothermal ablation in pancreatic adenocarcinoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy [Phase 2]
Exploratory Phase 2 trial evaluating combination treatment with adenovirus double suicide gene therapy for pancreas cancer; efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of PERT for exocrine pancreatic insufficiency in unresectable pancreatic cancer; study terminated with posted resul…
-
CLINICAL_TRIALS research · 2021-03-10Clinical Trial Update: Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
A completed clinical trial evaluating how a multi-media tool affects enrollment in oncology trials; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [Phase 2, Phase 3]
A clinical trial update on combination chemotherapy as first-line therapy for metastatic pancreatic cancer (Phase 2/3).
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without docetaxel in previously treated metastatic pancreatic cancer; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas [Phase 2]
Phase II study investigating pioglitazone for cancer of the pancreas has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating radiation therapy with docetaxel and either fluorouracil or cisplatin as first-line therapy for unresectable metast…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer [Phase 2]
A phase 2 trial investigating SBRT plus pembrolizumab and trametinib for pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating the combination of radiation therapy and anti-PD-1 antibody in pancreatic cancer is being reported.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) [Phase 2]
Phase 2 trial update for TAS-102 (Lonsurf) in metastatic or locally advanced unresectable pancreatic adenocarcinoma after first-line therapy…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial investigating short-course radiation therapy with proton or photon beam, capecitabine, and hydroxychloroquine for resectable p…